Trial intelligence / Profile preview

HSK21542 for postoperative orthopedic pain

CTR20243351Phase 2Completed

Sponsor
Liaoning Hisun Pharmaceutical
Start
Sep 2024
Modality
Small Molecules, Peptides
Countries
1
01

Overview

A Phase 2 trial of hsk21542 in postoperative pain, sponsored by Liaoning Hisun Pharmaceutical. Started Sep 2024; status: completed.

02

Drugs

hsk21542
03

Conditions

postoperative pain

Beyond the preview

Go deeper on CTR20243351.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20243351.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call